Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

Efficacy of Combined CO2 Fractional Laser With Bimatoprost 0.03% in Treatment of Alopecia Areata

The goal of this study is to evaluate the efficacy and safety of combined CO2 fractional laser with Bimatoprost 0.03% as novel treatment of alopecia areata.

The main question to study is will the bimatoprost facilitate hair growth if added to fractional CO2 laser treatment in Alopecia areata.

The study included 30 patients who were diagnosed clinically and dermoscopically as alopecia areata with age ranged between 16-55 years. The patients are divided into 2 groups: Group I, received fractional laser sessions with immediate and daily Bimatoprost application and Group II, received only frequent Laser sessions. Laser sessions were given to each patch once every 3 weeks, the procedure was repeated for 3 times.

Inclusion Criteria:

• Patients with alopecia areata of the scalp (multilocuolaris or single patch).
• Patient aged from 16- 55 years old in both sex.
• Other treatment wash out period is two months.

Exclusion Criteria:

• Ophiasis pattern and other patterns of alopecia areata.
• Chronic diseases of liver, heart, kidney and blood
• Pregnant women
• Infections of skin in site of intervention